Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Total Debt Growth (5y) (2014 - 2026)

Charles River Laboratories International (CRL) Total Debt Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn

Historic Data

Download Data
DateValue
Jun 27, 2026 -0.82%
Dec 27, 2025 1.53%
Jun 28, 2025 0.62%
Mar 29, 2025 1.12%
Dec 28, 2024 3.48%
Sep 28, 2024 3.96%
Jun 29, 2024 3.04%
Mar 30, 2024 11.10%
Dec 30, 2023 9.68%
Sep 30, 2023 8.34%
Jul 1, 2023 7.94%
Apr 1, 2023 19.36%
Dec 31, 2022 18.78%
Sep 24, 2022 19.96%
Jun 25, 2022 21.27%
Mar 26, 2022 17.47%
Dec 25, 2021 16.64%
Sep 25, 2021 18.12%
Jun 26, 2021 14.87%
Mar 27, 2021 20.67%